Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.

Given that the interaction terms were highly significant (p<0·001) for age, sex, homemaker service, and all diagnoses at baseline except asthma, vaccine effectiveness was also estimated in subgroups according to these covariates.

also in 132,142 other papers